AYDEMİR, E. Et Al. 2010. Combined treatment with radiotherapy and endostatin in breast cancer: Changes in substance P levels by activating ADAM-10, neprilysin.. ASCO Breast Cancer Symposium. , (Washington, United States Of America), 302.

AYDEMİR, E., ŞİMŞEK, E., KORCUM, A. F., ERİN, N., & FIŞKIN, K., (2010). Combined treatment with radiotherapy and endostatin in breast cancer: Changes in substance P levels by activating ADAM-10, neprilysin. . ASCO Breast Cancer Symposium. (pp.302). Washington, United States Of America

AYDEMİR, ESRA Et Al. "Combined treatment with radiotherapy and endostatin in breast cancer: Changes in substance P levels by activating ADAM-10, neprilysin.," ASCO Breast Cancer Symposium., Washington, United States Of America, 2010

AYDEMİR, ESRA Et Al. "Combined treatment with radiotherapy and endostatin in breast cancer: Changes in substance P levels by activating ADAM-10, neprilysin.." ASCO Breast Cancer Symposium. , Washington, United States Of America, pp.302, 2010

AYDEMİR, E. Et Al. (2010) . "Combined treatment with radiotherapy and endostatin in breast cancer: Changes in substance P levels by activating ADAM-10, neprilysin.." ASCO Breast Cancer Symposium. , Washington, United States Of America, p.302.

@conferencepaper{conferencepaper, author={ESRA AYDEMİR Et Al. }, title={Combined treatment with radiotherapy and endostatin in breast cancer: Changes in substance P levels by activating ADAM-10, neprilysin.}, congress name={ASCO Breast Cancer Symposium.}, city={Washington}, country={United States Of America}, year={2010}, pages={302} }